Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Selenozyme AB
AB
Active
Org 5592502271
Nanna Svartz Väg 2
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 721K
-24% vs 2023
EBITDA margin
15.6%
-66% vs 2023
Equity ratio
39.7%
Financial strength
Net profit 2024
SEK -17K
-108% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 721K
-24%
EBITDA
SEK 113K
-66%
Net profit
SEK -17K
-108%
Total assets
SEK 508K
-22%
Equity
SEK 201K
-8%
Employees
0
—
Company information
Legal name
Selenozyme AB
Org number
5592502271
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva forskning, utveckling och produktion av proteiner samt därmed förenlig verksamhet.
Contact
Address
Nanna Svartz Väg 2
Email
info@selenozyme.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Solna
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
3
801
941
951
721
Staff expenses
—
—
−462
−67
−39
EBITDA
−58
−268
117
336
113
Depreciation & amort.
−0
−44
−130
−130
−130
EBIT
−58
−312
−13
206
−17
Net financials
—
—
−0
0
0
Profit before tax
−58
−312
−13
206
—
Tax
−0
−0
—
—
—
Net profit
−58
−312
−13
206
−17
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
507
550
650
649
508
Equity
267
15
2
219
201
Long-term debt
0
0
—
—
—
Short-term debt
241
536
637
430
306
Total debt
241
536
637
430
306
Financial ratios
5-year trend
EBITDA margin
15.6%
This company
15.8%
Market median
+1% vs market
2020
2024
Equity ratio
39.7%
This company
38.2%
Market median
+4% vs market
2020
2024
Return on equity
-8.6%
This company
18.4%
Market median
-147% vs market
2020
2024
Net profit margin
-2.4%
This company
8.1%
Market median
-130% vs market
2020
2024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
2020
2024
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
QC
Qing Cheng
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ES
Elias Set Jenö Arnér
Chairman
2023
MT
Mohamad Takwa
Deputy Board Member
2023
Former (1)
SM
Sven Martin Linde
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Selenozyme AB also hold positions in
0
other companies.
Person
Role here
Other companies
Qing Cheng
Chief Executive Officer
0 companies
Elias Set Jenö Arnér
Chairman
0 companies
Mohamad Takwa
Deputy Board Member
0 companies
Sven Martin Linde
Board of Directors
0 companies